CAR T-cell Therapy: A Hopeful Option in Cancer Treatment
April 2017
Learn more about:
- Chimeric antigen receptor (CAR) T-cell therapy as an emerging treatment option
- The impact of clinical trials in the advancement of treatment for blood cancer patients
Support for this video provided by Juno Therapeutics, Kite Pharma, and Novartis.